Association between antiseizure medications and quality of life in epilepsy: A mediation analysis.

Meng Wang Kevin Perera Colin Bruce JosephsonMubasiru LamidiOluwaseyi A LawalOluwagbohunmi AwosogaPamela RoachScott B PattenSamuel Wiebe Tolulope T Sajobi

Published in: Epilepsia (2021)

These findings highlight the importance of managing depression and ASM side effects for improving health outcomes of patients requiring treatment with ASMs. Intervention programs aimed at improving HRQOL of patients with epilepsy need to target these potential mediators.

Keyphrases

end stage renal disease
ejection fraction
randomized controlled trial
newly diagnosed
chronic kidney disease
depressive symptoms
prognostic factors
social support
risk assessment
physical activity
patient reported outcomes